Dr Azfar Zaman
Hon Clin Reader in Cardiology
- Noman A, Das R, Balasubramaniam K, Kunadian V, Ivanauskiene T, Zaman A. Admission heart rate predicts mortality following Primary PCI for ST Elevation Myocardial Infarction: An observational study.
Cardiovascular Therapeutics 2013. In Press.
- Collins K, Balasubramaniam K, Viswanathan G, Natasari A, Tarn J, Lendrem D, Mitchell S, Zaman A, Ng W-F. Assessment of blood clot formation and platelet receptor function ex vivo in patients with primary Sjögren’s syndrome.
BMJ Open 2013. In Press.
- Kunadian V, Harper A, Bawamia B, Zaman A. Drug eluting stents versus bare metal stents in primary PCI.
Future Medicine 2013. In Press.
- Viswanathan GN, Balasubramaniam K, Harper AG, Bawamia B, Marshall SM, Badimon JJ, Zaman AG. Higher thrombus, altered clot kinetics and fibrin architecture in patients with type 2 diabetes mellitus after non ST elevation acute coronary syndrome.
In: Congress of the European Society of Cardiology (ESC). 2012, Munchen, Germany: Oxford University Press.
- Balasubramanian K, Viswanathan GN, Marshall SM, Zaman AG. Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapy.
Cardiology Research and Practice 2012, 909154.
- Kunadian V, Veerasamy M, Zaman A. Lack of gender difference and improved in-hospital mortality rates in patients with cardiogenic shock following primary percutaneous coronary intervention: a UK tertiary cardiac centre registry study.
In: Congress of the European Society of Cardiology (ESC). 2012, Munchen, Germany: Oxford University Press.
- Kunadian V, Pugh A, Zaman AG, Qiu WL. Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studies.
Coronary Artery Disease 2012, 23(7), 469-479.
- Bundhoo SS, Earp E, Ivanauskiene T, Kunadian V, Freeman P, Edwards R, Kinnaird TD, Zaman A, Anderson RA. Saphenous vein graft percutaneous coronary intervention via radial artery access: Safe and effective with reduced hospital length of stay.
American Heart Journal 2012, 164(4), 468-472.
- Viswanathan GN, Marshall SM, Schechter CB, Balasubramaniam K, Badimon JJ, Zaman AG. Thrombus and antiplatelet therapy in type 2 diabetes mellitus: A prospective study after non-ST elevation acute coronary syndrome and a randomised, blinded, placebo-controlled study in stable angina.
Thrombosis and Haemostasis 2012, 108(5), 937-945.
- Kidambi A, Mayurathan G, Viswanathan G, Schechter C, Zaman AG. Unfractionated Heparin during Elective PCI: Fixed Dose or Weight Adjusted?.
Cardiovascular Therapeutics 2012, 30(1), 1-4.
- Cubbon RM, Gale CP, Kearney LC, Schechter CB, Brooksby WP, Nolan J, Fox KAA, Rajwani A, Baig W, Groves D, Barlow P, Fisher AC, Batin PD, Kahn MB, Zaman AG, Shah AM, Byrne JA, Lindsay SJ, Sapsford RJ, Wheatcroft SB, Witte KK, Kearney MT. Changing Characteristics and Mode of Death Associated With Chronic Heart Failure Caused by Left Ventricular Systolic Dysfunction A Study Across Therapeutic Eras.
Circulation. Heart Failure 2011, 4(4), 396-403.
- Viswanathan G, Mayurathan G, Hildreth T, Worthley S, Zaman A. Health Related Quality of Life After Percutaneous Coronary Revascularisation in Patients with Previous Coronary Artery Bypass Grafts: A Two-Year Follow Up Study.
Applied Research in Quality of Life 2011, 6(3), 311-324.
- Kunadian V, Zaman A, Qiu WL. Revascularization among patients with severe left ventricular dysfunction: a meta-analysis of observational studies.
European Journal of Heart Failure 2011, 13(7), 773-784.
- Viswanathan GN, Jardine J, Bhardwaj M, Adams P, Marshall S, Zaman A. Better clinical outcomes of participants in clinical research: Trial effect of an observational study in patients with non ST elevation acute coronary syndrome (NSTE-ACS).
In: European Heart Journal: ESC Congress. 2010, Stockholm, Sweden: Oxford University Press.
- Cubbon RM, Gale CP, Kearney LC, Brooksby P, Nolan J, Fox KA, Rajwani A, Baig W, Batin PD, Kahn MB, Zaman AG, Shah A, Lindsay S, Sapsford RJ, Wheatcroft SB, Witte KK, Kearney MT. Changing Characteristics and Outcomes of Patients with Chronic Heart Failure due to Left Ventricular Systolic Dysfunction: a Study Across Therapeutic Eras.
In: American Heart Association Scientific Sessions. 2010, Chicago, Illinois, USA: Lippincott Williams & Wilkins.
- Viswanathan GN, Natarajan A, Marshall SM, Badimon JJ, Zaman AG. Higher Thrombus Burden and Impaired Clot Kinetics in Patients with Type 2 Diabetes Mellitus following Non ST-Elevation Acute Coronary Syndrome.
In: American Heart Association Scientific Sessions. 2010, Chicago, Illinois, USA: Lippincott Williams & Wilkins.
- Viswanathan GN, Nelson AJ, Thompson L, Marshall SM, Zaman AG. Thrombus burden and response to clopidogrel in patients with type 2 diabets mellitus presenting with non ST elevation acute coronary syndrome.
In: European Heart Journal: ESC Congress. 2010, Stockholm, Sweden: Oxford University Press.
- Martin D, Zaman A, Hacker J, Mendelow D, Birchall D. Analysis of haemodynamic factors involved in carotid atherosclerosis using computational fluid dynamics.
British Journal of Radiology 2009, 82(special issue 1), s33-38.
- Viswanathan G, Javed S, Mayurathan G, Sallehuddin S, Jamieson S, Zaman AG. Guidelines to Practice Gap in the Use of Glycoprotein IIb/IIIa Inhibitors: From ISAR-REACT to Overreact ?.
Journal of Interventional Cardiology 2009, 22(2), 163-168.
- Thomas HE, Avery PJ, Ahmed JM, Edwards R, Purcell I, Zaman AG, Arthur HM, Keavney BD. Local vessel injury following percutaneous coronary intervention does not promote early mobilisation of endothelial progenitor cells in the absence of myocardial necrosis.
Heart 2009, 95(7), 555-558.
- Campbell PG, Teo KSL, Worthley SG, Kearney MT, Tarique A, Natarajan A, Zaman AG. Non-invasive assessment of saphenous vein graft patency in asymptomatic patients.
British Journal of Radiology 2009, 82(976), 291-295.
- Kunadian V, Zaman A, Qiu W. Sodium Bicarbonate For The Prevention Of Contrast Induced Nephropathy: A Meta-Analysis.
In: SCAI’s 32nd Annual Scientific Sessions. 2009, Las Vegas, Nevada, USA.
- Lo TS, Zaman AG, Stables R, Fraser D, Oldryod KG, Hildick-Smith D, Nolan J. Comparison of operator radiation exposure with optimized radiation protection devices during coronary angiograms and ad hoc percutaneous coronary interventions by radial and femoral routes.
European Heart Journal 2008, 29(17), 2180-2180.
- Hobson AR, McKenzie DB, Kunadian V, Purcell I, Zaman A, Dawkins KD, Curzen N. Malignancy: An unrecognized risk factor for coronary stent thrombosis?.
Journal of Invasive Cardiology 2008, 20(4), E120-E123.
- Natarajan A, Zaman AG, Marshall SM. Platelet hyperactivity in type 2 diabetes: Role of antiplatelet agents.
Diabetes and Vascular Disease Research 2008, 5(2), 138-144.
- Natarajan A, Marshall SM, Worthley SG, Badimon JJ, Zaman AG. The presence of coronary artery disease increases platelet-dependent thrombosis in patients with type 2 diabetes mellitus.
Journal of Thrombosis and Haemostasis 2008, 6(12), 2210-2213.
- McClure SJ, Gall S, Schechter CB, Kearney M, Zaman AG. Percutaneous Coronary Revascularization Reduces Plasma N-Terminal Pro-B-Type Natriuretic Peptide Concentration in Stable Coronary Artery Disease.
Journal of the American College of Cardiology 2007, 49(25), 2394-2397.
- Birchall D, Zaman A, Hacker J, Davies G, Mendelow D. Analysis of haemodynamic disturbance in the atherosclerotic carotid artery using computational fluid dynamics.
European Radiology 2006, 16(5), 1074-1083.
- Zaman AG, Kearney MT, Schecter C, Worthley SG, Nolan J. Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation.
American Heart Journal 2004, 147(5), 823-827.
- Kearney MT, Nolan J, Lee AJ, Brooksby PW, Prescott R, Shah AM, Zaman AG, Eckberg DL, Lindsay HS, Batin PD, Andrews R, Fox KAA. A prognostic index to predict long-term mortality in patients with mild to moderate chronic heart failure stabilised on angiotensin converting enzyme inhibitors.
European Journal of Heart Failure 2003, 5(4), 489-497.
- Zaman AG. Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarction.
New England Journal of Medicine 2003, 349(22), 2168-2168.
- Kearney MT, Zaman AG, Eckberg DL, Lee AJ, Fox K, Prescott RJ, Wright DJ, Shah A, Nolan J. Mortality, autonomic and myocardial abnormalities in chronic heart failure patients with markedly prolonged ventricular activation.
In: Circulation: American Heart Association Abstracts From Scientific Sessions. 2002, Chicago, Illinois, USA: Lippincott Williams & Wilkins.
- Kearney MT, Fox KAA, Lee AJ, Prescott RJ, Shah AM, Batin PD, Baig W, Lindsay S, Callahan TS, Shell WE, Eckberg DL, Zaman AG, Williams S, Neilson JMM, Nolan J. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure.
Journal of the American College of Cardiology 2002, 40(10), 1801-1808.
- Helft G, Worthley SG, Fuster V, Fayad ZA, Zaman AG, Corti R, Fallon JT, Badimon JJ. Progression and Regression of Atherosclerotic Lesions Monitoring With Serial Noninvasive Magnetic Resonance Imaging.
Circulation 2002, 105(8), 993-998.
- Osende JI, Badimon JJ, Fuster V, Herson P, Rabito P, Vidhun R, Zaman A, Rodriguez OJ, Lev EI, Rauch U, Heflt G, Fallon JT, Crandall JP. Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control.
Journal of the American College of Cardiology 2001, 38(5), 1307-1312.
- Gall NP, Kearney MT, Zaman A, O'Nunain S, Fox KAA, Flapan A, Nolan J. Implementation of the NICE guidelines for the primary prevention of mortality from ventricular tachyarrhythmias: implications for UK electrophysiology centres; activity modelling from the UK-HEART study.
Heart 2001, 86(2), 219-220.
